VKTX Stock Heads Toward Worst Day In Over A Year Just Days After Promising Weight Loss Drug Data — Here’s What’s Driving The Selloff

Shares of Viking Therapeutics (VKTX) fell more than 12% in pre-market trading on Thursday, putting them on track for their worst session in more than a year, after the biotech firm priced an upsized stock and convertible debt offering at a discount, just days after reporting promising data for its…